Ignite Creation Date:
2024-05-06 @ 8:06 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06256926
Status:
COMPLETED
Last Update Posted:
2024-02-13
First Post:
2021-12-08
Brief Title:
A Clinical Study of Curcuvail in Patients With Non-alcoholic Fatty Liver Disease
Sponsor:
COD Research Private Ltd
Organization:
COD Research Private Ltd
Study Overview
Official Title:
A Prospective Randomized Double Blind Placebo Controlled Parallel Group Study to Evaluate the Safety and Efficacy of Curcuvail of K Patel Phyto Extractions Pvt Ltd in Patients With Non-alcoholic Fatty Liver Disease NAFLD
Status:
COMPLETED
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
NAFLD
Brief Summary:
Nonalcoholic fatty liver disease NAFLD is the most common cause of chronic liver disease It comprises a wide spectrum of disorders that range from simple steatosis to nonalcoholic steatohepatitis NASH advanced fibrosis related cirrhosis and even hepatocellular carcinoma HCC
Detailed Description:
Nonalcoholic fatty liver disease NAFLD is the most common cause of chronic liver disease It comprises a wide spectrum of disorders that range from simple steatosis to nonalcoholic steatohepatitis NASH advanced fibrosis related cirrhosis and even hepatocellular carcinoma HCC
Currently there are no effective medications to cure NAFLD Current treatments for NAFLD include weight reduction through lifestyle modification and exercise insulin-sensitizing agents lipid-lowering agents and hepatoprotective drugs However the efficacy of these therapies is not satisfactory some drugs may even induce liver toxicity Thus it is necessary to develop novel therapies that are effective and safe for the treatment of NAFLD
Hence K Patel Phyto Extractions Pvt Ltd has formulated Curcuvail Objective of the current study is to compare efficacy safety and tolerability of test formulation Curcuvail by administering the medications in the adult patients suffering from Non-alcoholic Fatty Liver Disease NAFLD and eligible to receive Curcuvail as treatment
Currently there are no effective medications to cure NAFLD Current treatments for NAFLD include weight reduction through lifestyle modification and exercise insulin-sensitizing agents lipid-lowering agents and hepatoprotective drugs However the efficacy of these therapies is not satisfactory some drugs may even induce liver toxicity Thus it is necessary to develop novel therapies that are effective and safe for the treatment of NAFLD
Hence K Patel Phyto Extractions Pvt Ltd has formulated Curcuvail Objective of the current study is to compare efficacy safety and tolerability of test formulation Curcuvail by administering the medications in the adult patients suffering from Non-alcoholic Fatty Liver Disease NAFLD and eligible to receive Curcuvail as treatment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| CSI2003 Version 20 | OTHER | K Patel Phyto Extractions Pvt Ltd | None |